
Promestriene
CAS No. 39219-28-8
Promestriene ( —— )
产品货号. M14348 CAS No. 39219-28-8
Promestriene (INN) 是一种合成雌激素和糖皮质激素,以 1% 乳膏配方局部使用。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥243 | 有现货 |
![]() ![]() |
5MG | ¥381 | 有现货 |
![]() ![]() |
10MG | ¥616 | 有现货 |
![]() ![]() |
25MG | ¥1256 | 有现货 |
![]() ![]() |
50MG | ¥1847 | 有现货 |
![]() ![]() |
100MG | ¥2762 | 有现货 |
![]() ![]() |
200MG | ¥3580 | 有现货 |
![]() ![]() |
500MG | ¥5905 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Promestriene
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Promestriene (INN) 是一种合成雌激素和糖皮质激素,以 1% 乳膏配方局部使用。
-
产品描述Promestriene (INN) is a synthetic estrogen and glucocorticoid used topically in a 1% cream formulation. It is described as a tropic agent and antiseborrheic.(In Vitro):Promestriene is an analogue of oestradiol which is minimally absorbed and devoid of systemic effects when administered intravaginally, either as gynecological cream or capsules.Topical Promestriene is minimally absorbed with chronic use and has been reported to significantly improve the symptoms of vaginal atrophy.
-
体外实验Promestriene is an analogue of oestradiol which is minimally absorbed and devoid of systemic effects when administered intravaginally, either as gynecological cream or capsules.Topical Promestriene is minimally absorbed with chronic use and has been reported to significantly improve the symptoms of vaginal atrophy.
-
体内实验——
-
同义词——
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体ER
-
研究领域——
-
适应症——
化学信息
-
CAS Number39219-28-8
-
分子量328.49
-
分子式C22H32O2
-
纯度>98% (HPLC)
-
溶解度Water: 10 mM
-
SMILESCCCOC1=CC2=C(C=C1)[C@H]3CC[C@]4([C@H]([C@@H]3CC2)CC[C@@H]4OC)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Del Pup L, et al. anticancer Drugs. 2013 Nov;24(10):989-98.
产品手册




关联产品
-
Diarylpropionitrile
二芳基丙腈 (DPN) 是一种非甾体雌激素受体 β(ERβ) 选择性配体。
-
Etonogestrel
Etonogestrel (3-Oxodesogestrel) 是孕激素去氧孕烯的生物活性代谢物,Etonogestrel 与靶器官中的孕酮受体 (progesterone receptor) 和雌激素受体 (estrogen receptors) 高亲和力地结合。Etonogestrel 诱导 FKBP51 mRNA 和蛋白表达。
-
Droloxifene
一种非类固醇选择性雌激素受体调节剂 (SERM),与他莫昔芬相比,对雌激素受体的亲和力增加 10 至 60 倍。